Role of drug-reaction monitoring in the investigation of thrombosis and "the pill".
作者信息
Inman W H
出版信息
Br Med Bull. 1970 Sep;26(3):248-56. doi: 10.1093/oxfordjournals.bmb.a070793.
Abstract
摘要
相似文献
1
Role of drug-reaction monitoring in the investigation of thrombosis and "the pill".药物反应监测在血栓形成与“避孕药”研究中的作用
Br Med Bull. 1970 Sep;26(3):248-56. doi: 10.1093/oxfordjournals.bmb.a070793.
2
An analysis of the reported association of oral contraceptives to thromboembolic disease.关于口服避孕药与血栓栓塞性疾病之间所报道关联的分析。
West J Med. 1975 Jan;122(1):26-33.
3
Oral contraceptives and mortality trends from thromboembolism in the United States.美国口服避孕药与血栓栓塞导致的死亡率趋势
Am J Public Health Nations Health. 1969 Mar;59(3):418-34. doi: 10.2105/ajph.59.3.418.
4
Oral contraceptives and thromboembolism.
Med Lett Drugs Ther. 1972 Aug 18;14(17):61-2.
5
Combined oral contraceptives. A statement by the committee on safety of drugs.复方口服避孕药。药物安全委员会声明。
Br Med J. 1970 Apr 25;2(5703):231-2. doi: 10.1136/bmj.2.5703.231.
6
Estrogens and thromboembolic diseases. Present conception of a controversial issue.
Acta Obstet Gynecol Scand Suppl. 1976;54:13-28.
7
Thromboembolic disease and the pill.血栓栓塞性疾病与避孕药丸
Br Med J. 1970 Sep 12;3(5723):644. doi: 10.1136/bmj.3.5723.644-b.
8
The pill and circulatory disease.药丸与循环系统疾病。
Am Heart J. 1979 Feb;97(2):263-4. doi: 10.1016/0002-8703(79)90365-x.
9
Oral contraceptives and thromboembolic disease.口服避孕药与血栓栓塞性疾病。
Am Heart J. 1969 Feb;77(2):153-7. doi: 10.1016/0002-8703(69)90344-5.
10
Oral contraceptives containing oestrogens.含雌激素的口服避孕药。
Lancet. 1969 Dec 20;2(7634):1369. doi: 10.1016/s0140-6736(69)90920-9.
引用本文的文献
1
Adverse reactions to new drugs.新药的不良反应。
Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):719-20. doi: 10.1136/bmj.286.6366.719-b.
2
Evaluation of spontaneous reports of adverse reactions to drugs.药物不良反应自发报告的评估
Br Med J. 1972 Sep 23;3(5829):746-9. doi: 10.1136/bmj.3.5829.746.
3
Death after taking medicaments.服药后死亡。
Br Med J. 1974 Mar 16;1(5906):501-4. doi: 10.1136/bmj.1.5906.501.
Zotero 插件